Degenerative Mitral Regurgitation: From Prolapse to Precision Therapy

Degenerative mitral valve regurgitation due to mitral valve prolapse affects ≈15 million people globally and is the commonest indication for mitral intervention in high-income countries, but its biology, natural history, and lifetime management are ill defined. This review summarizes current knowledge of the epidemiology, pathophysiology, diagnosis, risk stratification, and lifetime management of degenerative mitral regurgitation, with a focus on areas of uncertainty, recent advances, and emerging research directions. These include translational research focused on determining genetic and cellular drivers of disease progression and mechanistic studies geared to improve detection and prevention of downstream myocardial dysfunction, particularly in high-risk phenotypes, including arrhythmic mitral prolapse. The current landscape of randomized trials and large registries comparing contemporary surgical and transcatheter treatment and strategies to improve patient access to care and outcomes across all patient risk profiles and populations are also discussed.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2026-11-16
DOI
https://doi.org/10.1161/circulationaha.126.081203
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Degenerative Mitral Regurgitation: From Prolapse to Precision Therapy

Annetine C. Gelijns, Francesca Nesta Delling, Joanna Chikwe
Circulation
Cardiac Valve Diseases and Treatments
article

Degenerative Mitral Regurgitation: From Prolapse to Precision Therapy

Annetine C. Gelijns, Francesca Nesta Delling, Joanna Chikwe
article en

Abstract

Degenerative mitral valve regurgitation due to mitral valve prolapse affects ≈15 million people globally and is the commonest indication for mitral intervention in high-income countries, but its biology, natural history, and lifetime management are ill defined. This review summarizes current knowledge of the epidemiology, pathophysiology, diagnosis, risk stratification, and lifetime management of degenerative mitral regurgitation, with a focus on areas of uncertainty, recent advances, and emerging research directions. These include translational research focused on determining genetic and cellular drivers of disease progression and mechanistic studies geared to improve detection and prevention of downstream myocardial dysfunction, particularly in high-risk phenotypes, including arrhythmic mitral prolapse. The current landscape of randomized trials and large registries comparing contemporary surgical and transcatheter treatment and strategies to improve patient access to care and outcomes across all patient risk profiles and populations are also discussed.

CirculationVol. 154(20)
Cedars-Sinai Medical Center (US)
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon